Republic Of Korea to India: Paclitaxel Import Trade Route
India has recorded 1 verified shipments of Paclitaxel imported from Republic Of Korea, representing a combined trade value of $150.9K USD. This corridor is served by 1 active Republic Of Korea exporters, with an average shipment value of $150.9K USD. The leading Republic Of Korea supplier is SAMYANG HOLDINGS CORPORATION, which accounts for 100% of total import value with 1 shipments worth $150.9K USD. On the buying side, LUPIN LIMITED is the largest Indian importer with $150.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The Republic Of Korea to India Paclitaxel corridor is one of India's established pharmaceutical import routes from Republic Of Korea, with 1 shipments documented worth a combined $150.9K USD. The route is dominated by SAMYANG HOLDINGS CORPORATION, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Republic Of Korea's paclitaxel export sector.
Across 1 active Republic Of Korea suppliers, the average shipment value stands at $150.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with paclitaxel's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 20.2%, placing it at rank #15 among India's top paclitaxel import origins globally.
On the Indian buyer side, key Indian importers include LUPIN LIMITED. LUPIN LIMITED is the single largest Indian importer with 1 shipments valued at $150.9K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeSea freight
- Top port of entrySAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#15
- Annual growth+20.2%
- Demand growth+17.3%
- Regulatory ease76/100
Top 10 Paclitaxel Exporters from Republic Of Korea to India
Showing top 10 of 1 Republic Of Korea suppliers exporting Paclitaxel to India, ranked by total trade value (USD)
| Rank | Supplier (Republic Of Korea Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SAMYANG HOLDINGS CORPORATION Avg $150.9K per shipment | 1 | $150.9K | 100.0% |
This table shows the top 10 of 1 Republic Of Korea companies exporting paclitaxel to India, ranked by total trade value. The listed exporters are: SAMYANG HOLDINGS CORPORATION. SAMYANG HOLDINGS CORPORATION is the dominant supplier with 1 shipments worth $150.9K USD, giving it a 100% market share.
Top 10 Indian Paclitaxel Importers from Republic Of Korea
Showing top 10 of 1 known Indian buyers receiving Paclitaxel shipments from Republic Of Korea, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Republic Of Korea paclitaxel include LUPIN LIMITED. The largest importer is LUPIN LIMITED, accounting for $150.9K USD across 1 shipments — representing 100% of all paclitaxel imports from Republic Of Korea on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED | 1 | $150.9K | 100.0% |
Top 10 Paclitaxel Formulations Imported from Republic Of Korea
Showing top 10 of 1 product formulations shipped on the Republic Of Korea to India Paclitaxel route, ranked by trade value
India imports a wide range of paclitaxel formulations from Republic Of Korea, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GENEXOL PM 100 MG INJECTION (PACLITAXEL 100MG/VIAL) GENEXOL PM 100 MG INJECTION (PACLITAXEL 100MG/VIAL) — accounts for $150.9K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GENEXOL PM 100 MG INJECTION (PACLITAXEL 100MG/VIAL) GENEXOL PM 100 MG INJECTION (PACLITAXEL 100MG/VIAL) | 1 | $150.9K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 1 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's paclitaxel imports from Republic Of Korea are driven primarily by a handful of large-scale Republic Of Korea manufacturers. SAMYANG HOLDINGS CORPORATION with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Republic Of Korea supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SAMYANG HOLDINGS CORPORATION — together account for 100% of total trade value on this route. The average shipment value of $150.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
On the buying side, LUPIN LIMITED is the largest importer with 1 shipments worth $150.9K USD — representing 100% of all paclitaxel imports from Republic Of Korea on this route.
Route Statistics
- Trade Volume
- $150.9K
- Avg. Shipment
- $150.9K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~16 days
- Annual Growth
- +20.2%
Related Analysis
Other Paclitaxel Routes
Unlock the Full Republic Of Korea to India Paclitaxel Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — Republic Of Korea to India Paclitaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Republic Of Korea companies export Paclitaxel to India?
The leading Republic Of Korea exporters of Paclitaxel to India are SAMYANG HOLDINGS CORPORATION. SAMYANG HOLDINGS CORPORATION holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Paclitaxel imports from Republic Of Korea to India?
India imports Paclitaxel from Republic Of Korea worth approximately $150.9K USD across 1 recorded shipments. The average value per shipment is $150.9K USD.
Q Which Indian ports receive Paclitaxel from Republic Of Korea?
The most active Indian port of entry is SAHAR AIR CARGO ACC (INBOM4) with 1 shipments. Republic Of Korea exporters primarily use sea freight for this route, with 74% of shipments going by sea and 21% by air.
Q How long does shipping take from Republic Of Korea to India for Paclitaxel?
The average transit time for Paclitaxel shipments from Republic Of Korea to India is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the Republic Of Korea to India Paclitaxel import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.2% with demand growth tracking at 17.3%. The route is ranked #15 among India's top Paclitaxel import origins globally.
Q How many Republic Of Korea suppliers are active on this Paclitaxel import route?
There are currently 1 active Republic Of Korea suppliers exporting Paclitaxel to India. The market is moderately concentrated with SAMYANG HOLDINGS CORPORATION accounting for 100% of total shipment value.
Q Who are the main Indian importers of Paclitaxel from Republic Of Korea?
The leading Indian importers of Paclitaxel from Republic Of Korea include LUPIN LIMITED. LUPIN LIMITED is the largest buyer with 1 shipments worth $150.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Republic Of Korea export trade corridor identified from Indian Customs (DGFT) records for Paclitaxel.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Republic Of Korea matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists